Synergy testing by etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4678-4683

  Sopirala, Madhuri M ^a   Mangino, Julie E ^a   Gebreyes, Wondwossen A ^a   Biller, Beth ^a   Bannerman, Tammy ^b   Balada Llasat, Joan Miquel ^a   Pancholi, Preeti ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; COLESTIMETHATE; IMIPENEM; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BROTH DILUTION; DISK DIFFUSION; DRUG EFFICACY; DRUG POTENTIATION; EPSILOMETER TEST; ESCHERICHIA COLI; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; TIME KILL METHOD; TREATMENT RESPONSE; YERSINIA PESTIS;

ACINETOBACTER BAUMANNII; AMIKACIN; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 78049319832     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00497-10     Document Type: Article

References (30)

1. Afzal-Shah, M., and D. M. Livermore. 1998. Worldwide emergence of carbapenem-resistant Acinetobacter. J. Antimicrob. Chemother. 41:576-577.
2. Amyes, S. G. B., and H.-K. Young. 1996. Mechanism of antibiotic resistance in Acinetobacter spp.: genetics of resistance, p. 185-223. In E. Bergogne-Berezin, M. L. Joly-Guillou, and K. J. Towner (ed.), Acinetobacter: microbiology, epidemiology, infections, management. CRC Press, New York, NY.
3. Bergogne-Berezin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
4. Bou, G., and J. Martïnez-Beltran. 2000. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44:428-432.
5. Brown, S., C. Bantar, H. K. Young, and S. G. B. Amyes. 1998. Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2. Lancet 351:186-187.
6. CLSI. 2009. M100-S19: performance standards for antimicrobial susceptibility testing; nineteenth informational supplement, vol. 29, no. 3. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Eliopoulos, G. M., and R. C. Mollering, Jr. 1996. Antimicrobial combinations, p. 330-396. In V. Lorain (ed.), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, MD.
8. Fournier, P. E., and H. Richet. 2006. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis. 42:692-699.
9. Giacometti, A., O. Cirioni, M. S. Del Prete, F. Barchiesi, A. Mataloni Paggi, E. Petrelli, and G. Scalise. 2000. Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 46:807-810.
10. Go, E., C. Urban, J. Burns, B. Kreiswirth, W. Eisner, N. Mariano, K. Mosinka-Snipas, and J. J. Rahal. 1994. Clinical and molecular epidemiology of Acinetobacter sensitive only to polymyxin B and sulbactam. Lancet 344: 1329-1332.
11. Hornstein, M., C. Sautjeau-Rostoker, J. Peduzzi, A. Vessieres, L. T. Hong, M. Barthelemy, M. Scavizzi, and R. Labia. 1997. Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in Acinetobacter baumannii. FEMS Microbiol. Lett. 153:333-339.
12. Manikal, V. M., D. Landman, G. Saurina, E. Oydna, H. Lai, and J. Quale. 2000. Endemic carbapenem resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, inter-institutional spread, and relation to antibiotic usage. Clin. Infect. Dis. 31:101-106.
13. Moody, J. A. 1992. Synergy testing: broth microdilution checkerboard and broth macrodilution methods, p. 5.18.1-5.18.23. In H. D. Eisenberg (ed.), Clinical microbiology procedures handbook. American Society for Microbiology, Washington, DC.
14. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline M26-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
15. Paton, R., R. S. Miles, J. Hood, and S. G. B. Amyes. 1993. ARI-1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2:81-88.
16. Perilli, M., A. Felici, A. Oratore, G. Cornaglia, G. Bonfiglio, G. M. Rossolini, and G. Amicosante. 1996. Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates. Antimicrob. Agents Chemother. 40:715-719.
17. Petersen, P. J., P. Labthavikul, C. H. Jones, and P. A. Bradford. 2006. In vitro antibacterial activities of tigecycline in combination with other antimicrobial antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J. Antimicrob. Chemother. 57:573-576.
18. Rand, K. H., H. J. Houck, P. Brown, et al. 1993. Reproducibility of the microdilution checkerboard method for antibiotic synergy. Antimicrob. Agents Chemother. 37:613-615.
19. Sato, K., and T. Nakae. 1991. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J. Antimicrob. Chemother. 28:33-45.
20. Schafer, J. J., D. A. Goff, K. B. Stevenson, and J. E. Mangino. 2007. Early experience with tigecycline for ventilator associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii. Pharmacotherapy 27:980-987.
21. Slover, C. M., K. A. Rodvold, and L. H. Danziger. 2007. Tigecycline: a novel broad-spectrum antimicrobial. Ann. Pharmacother. 41:965-972.
22. Sopirala, M. M., A. Pope-Harman, D. R. Nunley, S. Moffatt-Bruce, P. Ross, and S. I. Martin. 2008 Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients. J. Heart Lung Transplant. 27:804-807.
23. Stevenson, K. B., P. Kulich, S. York, T. Bannerman, and J. E. Mangino. 2006. Interfacility clonal transmission of multidrug-resistant Acinetobacter baumanni, presentation 309. SHEA Annu. Sci. Meet. (18 to 21 March 2006). Society for Helathcare Epidemiology of America, Arlington, VA.
24. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
25. Urban, C., N. Mariano, J. J. Rahal, E. Tay, C. Ponio, T. Koprivnjak, and J. Weiss. 2001. Polymyxin B-resistant Acinetobacter baumannii clinical isolates susceptible to recombinant BPI21 and cecropin P1. Antimicrob. Agents Chemother. 45:994-995.
26. Urban, C., S. Segal-Maurer, and J. J. Rahal. 2003. Considerations in control and treatment of nosocomial infection due to multi-drug-resistant Acinetobacter baumannii. Clin. Infect. Dis. 36:1268-1274.
27. Vahaboglu, H., R. Öztürk, G. Aygün, F. Coşkunkan, A. Yaman, A. Kaygusuz, H. Leblebicioglu, I. Balik, K. Aydin, and M. Otkun. 1997. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob. Agents Chemother. 41:2265-2269.
28. Vila, J., A. Marcos, F. Marco, S. Abdalla, Y. Vergara, R. Reig, R. Gomez-Lus, and T. Jiménez De Anta. 1993. In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 37:138-141.
29. Vila, J., M. Navia, J. Ruiz, and C. Casals. 1997. Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 41:2757-2759.
30. White, R., D. Burgess, M. Manduru, et al. 1996. Comparison of three different in vitro methods of detecting synergy: time kill, checkerboard, and E test. Antimicrob. Agents Chemother. 40:1914-1918.